FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

396017000: Dexamethasone sodium phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469957019 Dexamethasone sodium phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489644018 Dexamethasone sodium phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
21501000188116 dexaméthasone phosphate sodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
804901000172116 phosphate sodique de dexaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dexamethasone sodium phosphate (substance) Is a Dexamethasone (substance) false Inferred relationship Some
Dexamethasone sodium phosphate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dexamethasone (substance) false Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Synthetic glucocorticoid false Inferred relationship Some
Dexamethasone sodium phosphate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dexamethasone phosphate (substance) true Inferred relationship Some
Dexamethasone sodium phosphate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Immunosuppressant (substance) true Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Pregnane (substance) true Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Fluorinated corticosteroid true Inferred relationship Some
Dexamethasone sodium phosphate (substance) Is a Glucocorticoid (substance) true Inferred relationship Some
Dexamethasone sodium phosphate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
phosphate sodique de dexaméthasone 5mg/mL, fiole de 2 mL de solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate [musculoskeletal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 5mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 0.1% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phospha 4mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phospha 0.1% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phospha 0.05% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone phosphate + dexamethasone sodium phospha 1mg/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate + neomycin sulfate 1mg/3.5gm solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Product containing dexamethasone sodium phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone + neomycin sulfate 1mg/3.5mg ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Product containing dexamethasone sodium phosphate and neomycin sulfate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 0.05% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 1.0mg/mL ophthalmic solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 24mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 10mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 4mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 0.05% conventional release eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Dexamethasone sodium phosphate 0.1% conventional release eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dexamethasone sodium phosphate (substance) Inferred relationship Some
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and tobramycin (as tobramycin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 2
Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 2
Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dexamethasone sodium phosphate (substance) Inferred relationship Some 2
Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion and/or injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 1
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dexamethasone sodium phosphate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start